预防术后深静脉血栓形成和肺栓塞。
Prevention of postoperative deep venous thrombosis and pulmonary embolism.
作者信息
Carter A E, Eban R, Perrett R D
出版信息
Br Med J. 1971 Feb 6;1(5744):312-4. doi: 10.1136/bmj.1.5744.312.
Abstract
Two series of patients observed clinically and by phlebography suggest that one agent known to produce a reduction in platelet aggregation in vitro might be useful in reducing the incidence of deep venous thrombosis and pulmonary embolism postoperatively. The agent used in this study was hydroxychlorquine sulphate.
摘要
通过临床观察和静脉造影术观察的两组患者表明，一种已知在体外可降低血小板聚集的药物可能有助于降低术后深静脉血栓形成和肺栓塞的发生率。本研究中使用的药物是硫酸羟氯喹。
相似文献
1
Prevention of postoperative deep venous thrombosis and pulmonary embolism.预防术后深静脉血栓形成和肺栓塞。
Br Med J. 1971 Feb 6;1(5744):312-4. doi: 10.1136/bmj.1.5744.312.
2
Deep venous thrombosis with suspected pulmonary embolism: detection with combined CT venography and pulmonary angiography.疑似肺栓塞的深静脉血栓形成：联合CT静脉造影和肺血管造影检测
Radiology. 2001 May;219(2):498-502. doi: 10.1148/radiology.219.2.r01ma26498.
3
4
Using dual-detector helical CT angiography to detect deep venous thrombosis in patients with suspicion of pulmonary embolism: diagnostic value and additional findings.使用双探测器螺旋CT血管造影术检测疑似肺栓塞患者的深静脉血栓形成：诊断价值及其他发现。
AJR Am J Roentgenol. 2001 Apr;176(4):1035-9. doi: 10.2214/ajr.176.4.1761035.
5
Risk factors associated with the occurrence of silent pulmonary embolism in patients with deep venous thrombosis of the lower limb.下肢深静脉血栓形成患者发生无症状肺栓塞的相关危险因素。
Phlebology. 2014 Aug;29(7):442-6. doi: 10.1177/0268355513487331. Epub 2013 May 9.
6
Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis.深静脉血栓形成患者中频繁出现的无症状肺栓塞。
JAMA. 1994 Jan 19;271(3):223-5.
7
Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration.抗血小板治疗随机试验协作概述——III：手术和内科患者中抗血小板预防对静脉血栓形成和肺栓塞的降低作用。抗血小板试验协作组
BMJ. 1994 Jan 22;308(6923):235-46.
8
Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.深静脉血栓形成和肺栓塞。第1部分。初始治疗：通常使用低分子量肝素。
Prescrire Int. 2013 Apr;22(137):99-101, 103-4.
9
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.低剂量阿司匹林预防肺栓塞和深静脉血栓形成：肺栓塞预防（PEP）试验
Lancet. 2000 Apr 15;355(9212):1295-302.
10
[Postoperative deep venous thrombosis of legs and pulmonary embolism].[术后下肢深静脉血栓形成与肺栓塞]
Khirurgiia (Mosk). 1999(3):52-8.
引用本文的文献
1
Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy.青少年皮肌炎：诊断与治疗的新线索
Curr Treatm Opt Rheumatol. 2021 Mar;7(1):39-62. doi: 10.1007/s40674-020-00168-5. Epub 2021 Feb 6.
2
Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study.羟氯喹预防复发性流产的多中心随机安慰剂对照试验 BBQ 研究方案。
BMJ Open. 2019 Mar 20;9(3):e025649. doi: 10.1136/bmjopen-2018-025649.
3
Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients.羟氯喹在系统性红斑狼疮及抗磷脂抗体阳性患者中预防血栓形成的应用。
Curr Rheumatol Rep. 2011 Feb;13(1):77-80. doi: 10.1007/s11926-010-0141-y.
4
Asymptomatic pulmonary embolism. A common event in high risk patients.无症状性肺栓塞。高危患者中的常见情况。
Ann Surg. 1982 Mar;195(3):323-7. doi: 10.1097/00000658-198203000-00013.
5
Prophylaxis of venous thromboembolism: analysis of cost effectiveness.静脉血栓栓塞的预防：成本效益分析
Ann Surg. 1980 Feb;191(2):207-18. doi: 10.1097/00000658-198002000-00013.
6
Prevention of postoperative deep venous thrombosis in legs by orally administered hydroxychloroquine sulphate.口服硫酸羟氯喹预防腿部术后深静脉血栓形成。
Br Med J. 1974 Jul 13;3(5923):94-5. doi: 10.1136/bmj.3.5923.94.
7
Use of chloroquine in shock.氯喹在休克中的应用。
Can Anaesth Soc J. 1975 Nov;22(6):687-95. doi: 10.1007/BF03013317.
8
[Platelet chloroquine and serotonin. Demonstration of competitive inhibition of serotonin uptake].[血小板中的氯喹和血清素。血清素摄取竞争性抑制的证明]
Experientia. 1975 Feb 15;31(2):233-4. doi: 10.1007/BF01990723.
9
Platelets, thrombosis and drugs.血小板、血栓形成与药物。
Drugs. 1975;9(1):19-76. doi: 10.2165/00003495-197509010-00003.
10
Antithrombotic drugs: part II.抗血栓药物：第二部分。
Drugs. 1976;12(2):132-57. doi: 10.2165/00003495-197612020-00002.
本文引用的文献
1
Use of antimalarial drugs as "desludging" agents in vascular disease processes.抗疟药物在血管疾病进程中作为“去淤”剂的应用。
J Am Med Assoc. 1960 Apr 9;172:1630-3. doi: 10.1001/jama.1960.03020150054010.
2
PROTHROMBIN-TIME AND THROMBOTEST IN INJURED PATIENTS ON PROPHYLACTIC ANTICOAGULANT THERAPY.预防性抗凝治疗的受伤患者的凝血酶原时间和血栓试验
Lancet. 1964 Jan 18;1(7325):124-9. doi: 10.1016/s0140-6736(64)92218-4.
3
THE AGGREGATION OF BLOOD PLATELETS.血小板的聚集
J Physiol. 1963 Aug;168(1):178-95. doi: 10.1113/jphysiol.1963.sp007185.
4
5
The post-mortem incdence of pulmonary embolism in a hospital population.医院人群中肺栓塞的尸检发病率。
Br J Surg. 1968 May;55(5):347-52. doi: 10.1002/bjs.1800550506.
6
Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis.双嘧达莫对临床可检测到的深静脉血栓形成发生率的影响。
Lancet. 1969 Oct 4;2(7623):718-20. doi: 10.1016/s0140-6736(69)90429-2.
Zotero 插件